STRATA Skin Net Worth
STRATA Skin Net Worth Breakdown | SSKN |
STRATA Skin Net Worth Analysis
STRATA Skin's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including STRATA Skin's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of STRATA Skin's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform STRATA Skin's net worth analysis. One common approach is to calculate STRATA Skin's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares STRATA Skin's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing STRATA Skin's net worth. This approach calculates the present value of STRATA Skin's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of STRATA Skin's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate STRATA Skin's net worth. This involves comparing STRATA Skin's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into STRATA Skin's net worth relative to its peers.
Enterprise Value |
|
To determine if STRATA Skin is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding STRATA Skin's net worth research are outlined below:
| STRATA Skin Sciences generated a negative expected return over the last 90 days | |
| STRATA Skin Sciences has high historical volatility and very poor performance | |
| STRATA Skin Sciences has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 33.36 M. Net Loss for the year was (10.83 M) with profit before overhead, payroll, taxes, and interest of 18.12 M. | |
| STRATA Skin Sciences currently holds about 10.04 M in cash with (519 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.29. | |
| STRATA Skin Sciences has a frail financial position based on the latest SEC disclosures | |
| Roughly 64.0% of the company shares are owned by institutional investors | |
| Latest headline from gurufocus.com: STRATA Skin Sciences to Report Fourth Quarter and Year End 2024 |
STRATA Skin uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in STRATA Skin Sciences. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to STRATA Skin's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 29th of March 2024 Upcoming Quarterly Report | View | |
| 20th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 29th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
STRATA Skin Target Price Consensus
STRATA target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. STRATA Skin's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| One | Strong Buy |
Most STRATA analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand STRATA stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of STRATA Skin Sciences, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationSTRATA Skin Target Price Projection
STRATA Skin's current and average target prices are 2.68 and 16.00, respectively. The current price of STRATA Skin is the price at which STRATA Skin Sciences is currently trading. On the other hand, STRATA Skin's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Target Price
Analyst Consensus On STRATA Skin Target Price
Know STRATA Skin's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as STRATA Skin is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading STRATA Skin Sciences backward and forwards among themselves. STRATA Skin's institutional investor refers to the entity that pools money to purchase STRATA Skin's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Carmichael Hill & Associates Inc | 2024-09-30 | 300 | Jpmorgan Chase & Co | 2024-12-31 | 106 | Financial Perspectives Inc | 2024-12-31 | 101 | Bank Of America Corp | 2024-12-31 | 20.0 | Hanson Mcclain Inc | 2024-12-31 | 5.0 | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 1.0 | Acadian Asset Management Llc | 2024-12-31 | 0.0 | Northern Trust Investments N A | 2024-12-31 | 0.0 | Fmr Inc | 2024-09-30 | 0.0 | 22nw, Lp | 2024-12-31 | 537 K | Nantahala Capital Management, Llc | 2024-12-31 | 403.9 K |
Follow STRATA Skin's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 11.48 M.Market Cap |
|
Project STRATA Skin's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.35) | (0.36) | |
| Return On Capital Employed | (0.33) | (0.35) | |
| Return On Assets | (0.23) | (0.24) | |
| Return On Equity | (0.98) | (0.93) |
When accessing STRATA Skin's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures STRATA Skin's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of STRATA Skin's profitability and make more informed investment decisions.
Evaluate STRATA Skin's management efficiency
STRATA Skin Sciences has return on total asset (ROA) of (0.0885) % which means that it has lost $0.0885 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7349) %, meaning that it created substantial loss on money invested by shareholders. STRATA Skin's management efficiency ratios could be used to measure how well STRATA Skin manages its routine affairs as well as how well it operates its assets and liabilities. As of the 23rd of March 2025, Return On Tangible Assets is likely to drop to -0.36. In addition to that, Return On Capital Employed is likely to drop to -0.35. At this time, STRATA Skin's Non Current Assets Total are very stable compared to the past year. As of the 23rd of March 2025, Non Currrent Assets Other is likely to grow to about 304.8 K, while Total Assets are likely to drop about 30.1 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 4.18 | 3.97 | |
| Tangible Book Value Per Share | (0.38) | (0.36) | |
| Enterprise Value Over EBITDA | (7.47) | (7.84) | |
| Price Book Value Ratio | 1.36 | 1.43 | |
| Enterprise Value Multiple | (7.47) | (7.84) | |
| Price Fair Value | 1.36 | 1.43 | |
| Enterprise Value | 25.2 M | 23.3 M |
Understanding the management dynamics of STRATA Skin Sciences allows us to gauge its ability to sustain growth and profitability. This comprehensive analysis aids in determining the stock's value.
Enterprise Value Revenue 0.6188 | Revenue | Quarterly Revenue Growth (0.01) | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific STRATA Skin insiders, such as employees or executives, is commonly permitted as long as it does not rely on STRATA Skin's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases STRATA Skin insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
STRATA Skin Corporate Filings
8K | 20th of March 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 5th of December 2024 Other Reports | ViewVerify | |
| 22nd of November 2024 Other Reports | ViewVerify | |
10Q | 14th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
STRATA Skin Earnings Estimation Breakdown
The calculation of STRATA Skin's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of STRATA Skin is estimated to be -0.2625 with the future projection ranging from a low of -0.2625 to a high of -0.2625. Please be aware that this consensus of annual earnings estimates for STRATA Skin Sciences is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-0.26 Lowest | Expected EPS | -0.26 Highest |
STRATA Skin Earnings Projection Consensus
Suppose the current estimates of STRATA Skin's value are higher than the current market price of the STRATA Skin stock. In this case, investors may conclude that STRATA Skin is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and STRATA Skin's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2024 | Current EPS (TTM) | |
| 2 | 65.74% | -0.5207 | -0.2625 | -2.53 |
STRATA Skin Earnings per Share Projection vs Actual
Actual Earning per Share of STRATA Skin refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering STRATA Skin Sciences predict the company's earnings will be in the future. The higher the earnings per share of STRATA Skin, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.STRATA Skin Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as STRATA Skin, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of STRATA Skin should always be considered in relation to other companies to make a more educated investment decision.STRATA Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact STRATA Skin's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-11-12 | 2024-09-30 | -0.44 | -0.5207 | -0.0807 | 18 | ||
2024-08-14 | 2024-06-30 | -0.7 | -0.03 | 0.67 | 95 | ||
2024-05-15 | 2024-03-31 | -0.07 | -0.1 | -0.03 | 42 | ||
2024-03-27 | 2023-12-31 | -0.02 | -0.11 | -0.09 | 450 | ||
2023-11-14 | 2023-09-30 | -0.04 | -0.03 | 0.01 | 25 | ||
2023-08-09 | 2023-06-30 | -0.05 | -0.06 | -0.01 | 20 | ||
2023-05-15 | 2023-03-31 | -0.07 | -0.08 | -0.01 | 14 | ||
2023-03-31 | 2022-12-31 | -0.05 | 0.045 | 0.095 | 190 | ||
2022-11-09 | 2022-09-30 | -0.06 | -0.03 | 0.03 | 50 | ||
2022-08-10 | 2022-06-30 | -0.05 | -0.05 | 0.0 | 0 | ||
2022-05-11 | 2022-03-31 | -0.06 | -0.07 | -0.01 | 16 | ||
2022-03-21 | 2021-12-31 | -0.02 | -0.02 | 0.0 | 0 | ||
2021-11-10 | 2021-09-30 | -0.05 | -0.02 | 0.03 | 60 | ||
2021-08-16 | 2021-06-30 | -0.04 | 0.03 | 0.07 | 175 | ||
2021-05-12 | 2021-03-31 | -0.04 | -0.07 | -0.03 | 75 | ||
2021-03-24 | 2020-12-31 | -0.03 | -0.01 | 0.02 | 66 | ||
2020-11-10 | 2020-09-30 | -0.04 | -0.04 | 0.0 | 0 | ||
2020-08-11 | 2020-06-30 | -0.03 | -0.05 | -0.02 | 66 | ||
2020-05-12 | 2020-03-31 | -0.05 | -0.03 | 0.02 | 40 | ||
2020-03-17 | 2019-12-31 | -0.02 | 0.0089 | 0.0289 | 144 | ||
2019-11-14 | 2019-09-30 | -0.01 | -0.03 | -0.02 | 200 | ||
2019-08-13 | 2019-06-30 | -0.01 | -0.03 | -0.02 | 200 | ||
2019-05-14 | 2019-03-31 | -0.03 | -0.02 | 0.01 | 33 | ||
2019-03-23 | 2018-12-31 | -0.01 | -0.005 | 0.005 | 50 | ||
2018-11-13 | 2018-09-30 | -0.04 | -0.01 | 0.03 | 75 | ||
2018-08-13 | 2018-06-30 | -0.03 | -0.02 | 0.01 | 33 | ||
2018-05-15 | 2018-03-31 | -0.9 | 0.09 | 0.99 | 110 | ||
2017-12-31 | 2017-12-31 | -0.9 | 0.09 | 0.99 | 110 | ||
2017-11-09 | 2017-09-30 | -0.68 | -0.75 | -0.07 | 10 | ||
2017-08-10 | 2017-06-30 | -0.71 | -0.52 | 0.19 | 26 | ||
2017-05-11 | 2017-03-31 | -0.75 | -1.03 | -0.28 | 37 | ||
2017-03-09 | 2016-12-31 | -0.65 | -0.4 | 0.25 | 38 | ||
2016-11-10 | 2016-09-30 | -0.5 | -0.7 | -0.2 | 40 | ||
2016-08-11 | 2016-06-30 | -0.5 | 0.25 | 0.75 | 150 | ||
2016-05-12 | 2016-03-31 | -0.9 | -0.7 | 0.2 | 22 | ||
2016-03-10 | 2015-12-31 | -1.1 | -0.3 | 0.8 | 72 | ||
2015-11-12 | 2015-09-30 | -0.55 | -4.9 | -4.35 | 790 | ||
2015-08-13 | 2015-06-30 | -1.55 | -1.0 | 0.55 | 35 | ||
2015-05-14 | 2015-03-31 | -1.85 | -5.6 | -3.75 | 202 | ||
2015-03-30 | 2014-12-31 | -2.95 | -5.7 | -2.75 | 93 | ||
2014-11-12 | 2014-09-30 | -3.7 | -2.2 | 1.5 | 40 | ||
2013-11-06 | 2013-09-30 | -7.75 | -5.0 | 2.75 | 35 | ||
2013-08-07 | 2013-06-30 | -8.5 | -8.5 | 0.0 | 0 | ||
2013-04-30 | 2013-03-31 | -8.75 | -8.5 | 0.25 | 2 | ||
2013-03-05 | 2012-12-31 | -9.25 | -9.5 | -0.25 | 2 | ||
2012-11-07 | 2012-09-30 | -9.25 | -8.5 | 0.75 | 8 | ||
2012-08-07 | 2012-06-30 | -12.2 | -9.0 | 3.2 | 26 | ||
2012-05-03 | 2012-03-31 | -10.3 | -9.5 | 0.8 | 7 | ||
2012-03-09 | 2011-12-31 | -11.4 | -10.5 | 0.9 | 7 | ||
2011-11-04 | 2011-09-30 | -11.12 | -12.0 | -0.88 | 7 | ||
2011-08-05 | 2011-06-30 | -14.5 | -9.5 | 5.0 | 34 | ||
2011-05-03 | 2011-03-31 | -14.5 | -10.0 | 4.5 | 31 | ||
2011-03-03 | 2010-12-31 | -12.5 | -10.5 | 2.0 | 16 | ||
2010-11-05 | 2010-09-30 | -11.17 | -10.0 | 1.17 | 10 | ||
2010-08-06 | 2010-06-30 | -10.5 | -10.0 | 0.5 | 4 | ||
2010-05-10 | 2010-03-31 | -10.37 | -11.0 | -0.63 | 6 | ||
2010-03-04 | 2009-12-31 | -11.83 | -12.5 | -0.67 | 5 | ||
2009-11-09 | 2009-09-30 | -10.17 | -13.0 | -2.83 | 27 | ||
2009-07-24 | 2009-06-30 | -11.75 | -11.0 | 0.75 | 6 | ||
2009-05-11 | 2009-03-31 | -12.75 | -11.5 | 1.25 | 9 | ||
2009-03-02 | 2008-12-31 | -12.5 | -11.5 | 1.0 | 8 | ||
2008-08-08 | 2008-06-30 | -13.83 | -16.0 | -2.17 | 15 | ||
2008-05-08 | 2008-03-31 | -11.67 | -14.0 | -2.33 | 19 | ||
2008-03-12 | 2007-12-31 | -11.33 | -10.0 | 1.33 | 11 | ||
2007-11-08 | 2007-09-30 | -11.5 | -9.0 | 2.5 | 21 | ||
2007-08-29 | 2007-06-30 | -11 | -11.5 | -0.5 | 4 | ||
2007-05-09 | 2007-03-31 | -12.5 | -11.0 | 1.5 | 12 | ||
2007-03-15 | 2006-12-31 | -12.5 | -9.0 | 3.5 | 28 | ||
2006-11-14 | 2006-09-30 | -14.67 | -11.0 | 3.67 | 25 | ||
2006-08-10 | 2006-06-30 | -13.5 | -13.5 | 0.0 | 0 | ||
2006-05-10 | 2006-03-31 | -13.5 | -13.5 | 0.0 | 0 | ||
2006-03-29 | 2005-12-31 | -7.5 | -16.0 | -8.5 | 113 |
STRATA Skin Corporate Management
| Shmuel Gov | Chief Officer | Profile | |
| John Gillings | Principal Officer | Profile | |
| Robert Moccia | CEO Pres | Profile | |
| William MBA | Ex Chairman | Profile | |
| Michael Goodman | Head Sales | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STRATA Skin Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STRATA Skin. If investors know STRATA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STRATA Skin listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.53) | Revenue Per Share | Quarterly Revenue Growth (0.01) | Return On Assets | Return On Equity |
The market value of STRATA Skin Sciences is measured differently than its book value, which is the value of STRATA that is recorded on the company's balance sheet. Investors also form their own opinion of STRATA Skin's value that differs from its market value or its book value, called intrinsic value, which is STRATA Skin's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STRATA Skin's market value can be influenced by many factors that don't directly affect STRATA Skin's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between STRATA Skin's value and its price as these two are different measures arrived at by different means. Investors typically determine if STRATA Skin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STRATA Skin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.